Four Therapeutic Lung Studies Now Underway at St. Paul’s

Four new inflammatory airway disease trials are underway with the support of CHÉOS — staff will be providing coordinating and site management services. Dr. Del Dorscheid, a critical care and respiratory physician at St. Paul’s Hospital and researcher at the Centre for Heart Lung Innovation, is the principal investigator for all four of the studies. Three of the studies are examining…
Read More
TxCell, a developer of cellular immunotherapies based on regulatory T cells (Tregs) for inflammation, autoimmunity and transplantation, today announces it has exercised its exclusive option to in-license the intellectual property rights of one of its academic partners, the University of British Columbia (UBC), onto the HLA-A2 CAR-Treg program. This program, named TX200 in TxCell’s portfolio, should soon be tested in human…
Read More
Breakthrough discovery from UBC researcher discovers that permanent lung damage caused by chronic obstructive pulmonary disease (COPD) starts before patients even begin showing symptoms.  The discovery was made by Dr. Tillie-Louise Hackett, associate professor in the University of British Columbia’s faculty of medicine, that will drastically change how patients are treated for COPD, and is the leading cause of hospital…
Read More
The UBC Faculty of Medicine is pleased to recognized the Women’s Health Research Institute (WHRI) as a Faculty of Medicine Research Center, in recognition of its scientific contributions and its significance to the Faculty of Medicine’s mission and to the public’s health. By coming within the Faculty’s organizational structure as the Women’s Health Research Centre, WHRI will now have a…
Read More

Untangling the Brain’s “Wires” in the Virtual Space

The brain’s cells interact with one another in a very dense environment, some of them rearranging the exquisite network of cells when pruning old bits of neuron to form new connections and stronger lines of communication, or when repair is needed following injury. It is a dynamic process, and images in a textbook cannot convey the complexity of cell-to-cell interaction…
Read More
Roughly half of the western medicines used today were derived from naturally occurring plant metabolites. Plants produce over 200,000 of these specialized metabolites, but identifying medicinally useful ones is challenging, and obtaining sufficient quantities for human use poses an even greater challenge. Type-2 diabetes, a disease characterized by elevated blood glucose levels due to the body’s inefficient use of insulin,…
Read More
Shortly after WAT Medical’s leading product to treat nausea-induced vomiting, EmeTerm, received its FDA clearance earlier in April, it has now also received official clearance from Health Canada. Health Canada ensures all of its certified medical products are of the highest quality and are able to provide the best care for patients to improve their lives. WAT Medical has reached…
Read More
​Breast cancer is the most common cancer in women with one in nine developing the disease in her lifetime. This year, approximately 3,500 new cases of breast cancer are expected in the province of British Columbia. Treatments include surgery, radiation, chemotherapy, hormonal therapy or a combination depending on an individual’s disease. Now a new international study published in New England Journal of Medicine,…
Read More
Five FHS graduate students, who are citizens of Kenya, Botswana and Rwanda, were recently admitted as research fellows into the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) consortium. The fellowship recipients are Khumoekae Richard (PI: Ian Tietjen), Gisele Umviligihozo (PI: Mark Brockman), Lorato Maje (PI: Angela Kaida), Fredrick Omondi (PI: Zabrina Brumme) and Grace Mwashigadi (MPH programme). SANTHE connects students with a multinational network…
Read More